Cannapharma is proud to be the first company to receive an Innovate SMART grant for the development of cannabinoids. We believe this is an incredible opportunity for the CBD industry as it marks the first time the UK government has officially endorsed CBD, not just nominally but with actual financial support.
Over the last six months Cannapharma has been hard at work creating a state of the art facility, tailored towards the handling and testing of cannabinoids and the manufacturing of CBD products. This has made Cannapharma uniquely capable of manufacturing a vast range of CBD rich products. With internal testing and a fully capable research and development lab, Cannapharma can develop new products to bring to the consumer and pharmaceutical market.
On top of the state of the art lab, Cannapharma has also invested in a fully automated bottling and labelling production line. Meaning that we also have the capability to bottle already developed formulations for our B2B and white label customers.
At Cannapharma we put time and care into everything we do and are setting ourselves up to be a leader in the CBD industry for years to come.
